JENNIFER TAYLOR: Open Payments
NPI 1578503868 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,210 in 100 payments from 15 companies in 2025. Trend: 2023 $290 · 2024 $864 · 2025 $2,210
Food & beverage: $1,642Education: $568
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $716 |
| ABBVIE INC. | 25 | $340 |
| LEO Pharma Inc. | 7 | $239 |
| Galderma Laboratories, L.P. | 15 | $201 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $196 |
| GENZYME CORPORATION | 9 | $160 |
| Amgen Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $42 |
| Bard Peripheral Vascular, Inc. | 1 | $41 |
Products named: TREMFYA, ADBRY, SKYRIZI, NEMLUVIO, ILUMYA, DUPIXENT, RINVOQ, OTEZLA.
Industry payments across NC — which companies pay providers there.
